The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Puerarin Injection Market Research Report 2025
Synopsis
The global Puerarin Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Puerarin Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Puerarin Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Puerarin Injection include Medisan, Tianjin Tianyao Pharmaceutical, Youcare Pharmaceutical Group, Tiantai Mountain Pharmaceutical, China Res Double-Crane and Actiza Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Puerarin Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Puerarin Injection.
Report Scope
The Puerarin Injection market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Puerarin Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Puerarin Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medisan
Tianjin Tianyao Pharmaceutical
Youcare Pharmaceutical Group
Tiantai Mountain Pharmaceutical
China Res Double-Crane
Actiza Pharmaceutical
Segment by Type
50mg/1ml
100mg/2ml
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Puerarin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Puerarin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Puerarin Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Puerarin Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Puerarin Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Puerarin Injection include Medisan, Tianjin Tianyao Pharmaceutical, Youcare Pharmaceutical Group, Tiantai Mountain Pharmaceutical, China Res Double-Crane and Actiza Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Puerarin Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Puerarin Injection.
Report Scope
The Puerarin Injection market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Puerarin Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Puerarin Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medisan
Tianjin Tianyao Pharmaceutical
Youcare Pharmaceutical Group
Tiantai Mountain Pharmaceutical
China Res Double-Crane
Actiza Pharmaceutical
Segment by Type
50mg/1ml
100mg/2ml
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Puerarin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Puerarin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Puerarin Injection Market Overview
1.1 Product Overview and Scope of Puerarin Injection
1.2 Puerarin Injection Segment by Type
1.2.1 Global Puerarin Injection Market Value Comparison by Type (2024-2030)
1.2.2 50mg/1ml
1.2.3 100mg/2ml
1.3 Puerarin Injection Segment by Application
1.3.1 Global Puerarin Injection Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Puerarin Injection Market Size Estimates and Forecasts
1.4.1 Global Puerarin Injection Revenue 2019-2030
1.4.2 Global Puerarin Injection Sales 2019-2030
1.4.3 Global Puerarin Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Puerarin Injection Market Competition by Manufacturers
2.1 Global Puerarin Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Puerarin Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Puerarin Injection Average Price by Manufacturers (2019-2024)
2.4 Global Puerarin Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Puerarin Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Puerarin Injection, Product Type & Application
2.7 Puerarin Injection Market Competitive Situation and Trends
2.7.1 Puerarin Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Puerarin Injection Players Market Share by Revenue
2.7.3 Global Puerarin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Puerarin Injection Retrospective Market Scenario by Region
3.1 Global Puerarin Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Puerarin Injection Global Puerarin Injection Sales by Region: 2019-2030
3.2.1 Global Puerarin Injection Sales by Region: 2019-2024
3.2.2 Global Puerarin Injection Sales by Region: 2025-2030
3.3 Global Puerarin Injection Global Puerarin Injection Revenue by Region: 2019-2030
3.3.1 Global Puerarin Injection Revenue by Region: 2019-2024
3.3.2 Global Puerarin Injection Revenue by Region: 2025-2030
3.4 North America Puerarin Injection Market Facts & Figures by Country
3.4.1 North America Puerarin Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Puerarin Injection Sales by Country (2019-2030)
3.4.3 North America Puerarin Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Puerarin Injection Market Facts & Figures by Country
3.5.1 Europe Puerarin Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Puerarin Injection Sales by Country (2019-2030)
3.5.3 Europe Puerarin Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Puerarin Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Puerarin Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Puerarin Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Puerarin Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Puerarin Injection Market Facts & Figures by Country
3.7.1 Latin America Puerarin Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Puerarin Injection Sales by Country (2019-2030)
3.7.3 Latin America Puerarin Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Puerarin Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Puerarin Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Puerarin Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Puerarin Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Puerarin Injection Sales by Type (2019-2030)
4.1.1 Global Puerarin Injection Sales by Type (2019-2024)
4.1.2 Global Puerarin Injection Sales by Type (2025-2030)
4.1.3 Global Puerarin Injection Sales Market Share by Type (2019-2030)
4.2 Global Puerarin Injection Revenue by Type (2019-2030)
4.2.1 Global Puerarin Injection Revenue by Type (2019-2024)
4.2.2 Global Puerarin Injection Revenue by Type (2025-2030)
4.2.3 Global Puerarin Injection Revenue Market Share by Type (2019-2030)
4.3 Global Puerarin Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Puerarin Injection Sales by Application (2019-2030)
5.1.1 Global Puerarin Injection Sales by Application (2019-2024)
5.1.2 Global Puerarin Injection Sales by Application (2025-2030)
5.1.3 Global Puerarin Injection Sales Market Share by Application (2019-2030)
5.2 Global Puerarin Injection Revenue by Application (2019-2030)
5.2.1 Global Puerarin Injection Revenue by Application (2019-2024)
5.2.2 Global Puerarin Injection Revenue by Application (2025-2030)
5.2.3 Global Puerarin Injection Revenue Market Share by Application (2019-2030)
5.3 Global Puerarin Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medisan
6.1.1 Medisan Corporation Information
6.1.2 Medisan Description and Business Overview
6.1.3 Medisan Puerarin Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medisan Puerarin Injection Product Portfolio
6.1.5 Medisan Recent Developments/Updates
6.2 Tianjin Tianyao Pharmaceutical
6.2.1 Tianjin Tianyao Pharmaceutical Corporation Information
6.2.2 Tianjin Tianyao Pharmaceutical Description and Business Overview
6.2.3 Tianjin Tianyao Pharmaceutical Puerarin Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Tianjin Tianyao Pharmaceutical Puerarin Injection Product Portfolio
6.2.5 Tianjin Tianyao Pharmaceutical Recent Developments/Updates
6.3 Youcare Pharmaceutical Group
6.3.1 Youcare Pharmaceutical Group Corporation Information
6.3.2 Youcare Pharmaceutical Group Description and Business Overview
6.3.3 Youcare Pharmaceutical Group Puerarin Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Youcare Pharmaceutical Group Puerarin Injection Product Portfolio
6.3.5 Youcare Pharmaceutical Group Recent Developments/Updates
6.4 Tiantai Mountain Pharmaceutical
6.4.1 Tiantai Mountain Pharmaceutical Corporation Information
6.4.2 Tiantai Mountain Pharmaceutical Description and Business Overview
6.4.3 Tiantai Mountain Pharmaceutical Puerarin Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Tiantai Mountain Pharmaceutical Puerarin Injection Product Portfolio
6.4.5 Tiantai Mountain Pharmaceutical Recent Developments/Updates
6.5 China Res Double-Crane
6.5.1 China Res Double-Crane Corporation Information
6.5.2 China Res Double-Crane Description and Business Overview
6.5.3 China Res Double-Crane Puerarin Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 China Res Double-Crane Puerarin Injection Product Portfolio
6.5.5 China Res Double-Crane Recent Developments/Updates
6.6 Actiza Pharmaceutical
6.6.1 Actiza Pharmaceutical Corporation Information
6.6.2 Actiza Pharmaceutical Description and Business Overview
6.6.3 Actiza Pharmaceutical Puerarin Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Actiza Pharmaceutical Puerarin Injection Product Portfolio
6.6.5 Actiza Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Puerarin Injection Industry Chain Analysis
7.2 Puerarin Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Puerarin Injection Production Mode & Process
7.4 Puerarin Injection Sales and Marketing
7.4.1 Puerarin Injection Sales Channels
7.4.2 Puerarin Injection Distributors
7.5 Puerarin Injection Customers
8 Puerarin Injection Market Dynamics
8.1 Puerarin Injection Industry Trends
8.2 Puerarin Injection Market Drivers
8.3 Puerarin Injection Market Challenges
8.4 Puerarin Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Puerarin Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Puerarin Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Puerarin Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Puerarin Injection Sales (M Units) of Key Manufacturers (2019-2024)
Table 5. Global Puerarin Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Puerarin Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Puerarin Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Puerarin Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Puerarin Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Puerarin Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Puerarin Injection, Product Type & Application
Table 12. Global Key Manufacturers of Puerarin Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Puerarin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Puerarin Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Puerarin Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Puerarin Injection Sales by Region (2019-2024) & (M Units)
Table 18. Global Puerarin Injection Sales Market Share by Region (2019-2024)
Table 19. Global Puerarin Injection Sales by Region (2025-2030) & (M Units)
Table 20. Global Puerarin Injection Sales Market Share by Region (2025-2030)
Table 21. Global Puerarin Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Puerarin Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Puerarin Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Puerarin Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Puerarin Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Puerarin Injection Sales by Country (2019-2024) & (M Units)
Table 27. North America Puerarin Injection Sales by Country (2025-2030) & (M Units)
Table 28. North America Puerarin Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Puerarin Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Puerarin Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Puerarin Injection Sales by Country (2019-2024) & (M Units)
Table 32. Europe Puerarin Injection Sales by Country (2025-2030) & (M Units)
Table 33. Europe Puerarin Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Puerarin Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Puerarin Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Puerarin Injection Sales by Region (2019-2024) & (M Units)
Table 37. Asia Pacific Puerarin Injection Sales by Region (2025-2030) & (M Units)
Table 38. Asia Pacific Puerarin Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Puerarin Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Puerarin Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Puerarin Injection Sales by Country (2019-2024) & (M Units)
Table 42. Latin America Puerarin Injection Sales by Country (2025-2030) & (M Units)
Table 43. Latin America Puerarin Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Puerarin Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Puerarin Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Puerarin Injection Sales by Country (2019-2024) & (M Units)
Table 47. Middle East & Africa Puerarin Injection Sales by Country (2025-2030) & (M Units)
Table 48. Middle East & Africa Puerarin Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Puerarin Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Puerarin Injection Sales (M Units) by Type (2019-2024)
Table 51. Global Puerarin Injection Sales (M Units) by Type (2025-2030)
Table 52. Global Puerarin Injection Sales Market Share by Type (2019-2024)
Table 53. Global Puerarin Injection Sales Market Share by Type (2025-2030)
Table 54. Global Puerarin Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Puerarin Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Puerarin Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Puerarin Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Puerarin Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Puerarin Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Puerarin Injection Sales (M Units) by Application (2019-2024)
Table 61. Global Puerarin Injection Sales (M Units) by Application (2025-2030)
Table 62. Global Puerarin Injection Sales Market Share by Application (2019-2024)
Table 63. Global Puerarin Injection Sales Market Share by Application (2025-2030)
Table 64. Global Puerarin Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Puerarin Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Puerarin Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Puerarin Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Puerarin Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Puerarin Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Medisan Corporation Information
Table 71. Medisan Description and Business Overview
Table 72. Medisan Puerarin Injection Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Medisan Puerarin Injection Product
Table 74. Medisan Recent Developments/Updates
Table 75. Tianjin Tianyao Pharmaceutical Corporation Information
Table 76. Tianjin Tianyao Pharmaceutical Description and Business Overview
Table 77. Tianjin Tianyao Pharmaceutical Puerarin Injection Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Tianjin Tianyao Pharmaceutical Puerarin Injection Product
Table 79. Tianjin Tianyao Pharmaceutical Recent Developments/Updates
Table 80. Youcare Pharmaceutical Group Corporation Information
Table 81. Youcare Pharmaceutical Group Description and Business Overview
Table 82. Youcare Pharmaceutical Group Puerarin Injection Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Youcare Pharmaceutical Group Puerarin Injection Product
Table 84. Youcare Pharmaceutical Group Recent Developments/Updates
Table 85. Tiantai Mountain Pharmaceutical Corporation Information
Table 86. Tiantai Mountain Pharmaceutical Description and Business Overview
Table 87. Tiantai Mountain Pharmaceutical Puerarin Injection Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Tiantai Mountain Pharmaceutical Puerarin Injection Product
Table 89. Tiantai Mountain Pharmaceutical Recent Developments/Updates
Table 90. China Res Double-Crane Corporation Information
Table 91. China Res Double-Crane Description and Business Overview
Table 92. China Res Double-Crane Puerarin Injection Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. China Res Double-Crane Puerarin Injection Product
Table 94. China Res Double-Crane Recent Developments/Updates
Table 95. Actiza Pharmaceutical Corporation Information
Table 96. Actiza Pharmaceutical Description and Business Overview
Table 97. Actiza Pharmaceutical Puerarin Injection Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Actiza Pharmaceutical Puerarin Injection Product
Table 99. Actiza Pharmaceutical Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Puerarin Injection Distributors List
Table 103. Puerarin Injection Customers List
Table 104. Puerarin Injection Market Trends
Table 105. Puerarin Injection Market Drivers
Table 106. Puerarin Injection Market Challenges
Table 107. Puerarin Injection Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Puerarin Injection
Figure 2. Global Puerarin Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Puerarin Injection Market Share by Type in 2023 & 2030
Figure 4. 50mg/1ml Product Picture
Figure 5. 100mg/2ml Product Picture
Figure 6. Global Puerarin Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Puerarin Injection Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Global Puerarin Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Puerarin Injection Market Size (2019-2030) & (US$ Million)
Figure 12. Global Puerarin Injection Sales (2019-2030) & (M Units)
Figure 13. Global Puerarin Injection Average Price (US$/Unit) & (2019-2030)
Figure 14. Puerarin Injection Report Years Considered
Figure 15. Puerarin Injection Sales Share by Manufacturers in 2023
Figure 16. Global Puerarin Injection Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Puerarin Injection Players: Market Share by Revenue in 2023
Figure 18. Puerarin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Puerarin Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Puerarin Injection Sales Market Share by Country (2019-2030)
Figure 21. North America Puerarin Injection Revenue Market Share by Country (2019-2030)
Figure 22. United States Puerarin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Puerarin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Puerarin Injection Sales Market Share by Country (2019-2030)
Figure 25. Europe Puerarin Injection Revenue Market Share by Country (2019-2030)
Figure 26. Germany Puerarin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Puerarin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Puerarin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Puerarin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Netherlands Puerarin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Puerarin Injection Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Puerarin Injection Revenue Market Share by Region (2019-2030)
Figure 33. China Puerarin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Puerarin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Puerarin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Puerarin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Puerarin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Puerarin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Puerarin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Latin America Puerarin Injection Sales Market Share by Country (2019-2030)
Figure 41. Latin America Puerarin Injection Revenue Market Share by Country (2019-2030)
Figure 42. Mexico Puerarin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Puerarin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Puerarin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Puerarin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Puerarin Injection Sales Market Share by Country (2019-2030)
Figure 47. Middle East & Africa Puerarin Injection Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Puerarin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Puerarin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Puerarin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Puerarin Injection by Type (2019-2030)
Figure 52. Global Revenue Market Share of Puerarin Injection by Type (2019-2030)
Figure 53. Global Puerarin Injection Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Puerarin Injection by Application (2019-2030)
Figure 55. Global Revenue Market Share of Puerarin Injection by Application (2019-2030)
Figure 56. Global Puerarin Injection Price (US$/Unit) by Application (2019-2030)
Figure 57. Puerarin Injection Value Chain
Figure 58. Puerarin Injection Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
